linsidomine has been researched along with antipyrine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chamberlain, J; Gärtner, W; Ostrowski, J; Stockhausen, H; Wildgrube, HJ | 1 |
| Fouyas, IP; Kelly, PA; Ritchie, IM; Whittle, IR | 1 |
| Anggård, EE; Carrier, MJ; Quine, LA | 1 |
3 other study(ies) available for linsidomine and antipyrine
| Article | Year |
|---|---|
Liver function and pharmacokinetics of molsidomine and its metabolite 3-morpholinosydnonimine in healthy volunteers.
Topics: Adult; Antipyrine; Humans; Indocyanine Green; Infusions, Intravenous; Kinetics; Liver; Liver Function Tests; Models, Biological; Molsidomine | 1986 |
Cerebrovascular effects of nitric oxide manipulation in spontaneously hypertensive rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antipyrine; Autoradiography; Blood Pressure; Cerebrovascular Circulation; Disease Models, Animal; Hypertension; Indazoles; Infusions, Intravenous; Injections, Intravenous; Isotope Labeling; Male; Molsidomine; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Vasodilation; Vasodilator Agents | 1997 |
Effect of anti-oxidants on the degradation of SIN-1.
Topics: Antioxidants; Antipyrine; Biotransformation; Cytochrome c Group; Hydrogen Peroxide; Kinetics; Molsidomine; Nitrates; Oxidation-Reduction; Superoxide Dismutase | 1997 |